Sutro Biopharma Ownership | Who Owns Sutro Biopharma?
Sutro Biopharma Ownership Summary
Sutro Biopharma is owned by 77.34% institutional investors, 0.94% insiders, and 21.73% retail investors. Blackrock is the largest institutional shareholder, holding 11.24% of STRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.93% of its assets in Sutro Biopharma shares.
STRO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Sutro Biopharma | 77.34% | 0.94% | 21.73% |
Sector | Healthcare Stocks | 56.95% | 9.26% | 33.79% |
Industry | Biotech Stocks | 68.60% | 8.88% | 22.52% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 6.91M | 11.24% | $20.25M |
Blackrock funding, inc. /de | 7.59M | 9.26% | $13.97M |
Suvretta capital management | 7.46M | 9.10% | $13.73M |
Vanguard group | 4.21M | 5.13% | $7.74M |
Kynam capital management, lp | 3.64M | 4.44% | $6.70M |
Merck | 2.72M | 3.32% | $5.01M |
Vestal point capital, lp | 2.57M | 3.13% | $4.73M |
Point72 asset management | 2.20M | 2.68% | $4.04M |
Samsara biocapital | 2.20M | 2.68% | $4.04M |
Bioimpact capital | 2.16M | 2.63% | $3.97M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Merck | 2.72M | 1.94% | $5.01M |
Bioimpact capital | 2.16M | 0.56% | $3.97M |
Samsara biocapital | 2.20M | 0.55% | $4.04M |
Suvretta capital management | 7.46M | 0.47% | $13.73M |
Parkman healthcare partners | 1.73M | 0.42% | $3.18M |
Kynam capital management, lp | 3.64M | 0.40% | $6.70M |
Vestal point capital, lp | 2.57M | 0.28% | $4.73M |
Dafna capital management | 437.08K | 0.20% | $804.23K |
Eversept partners, lp | 694.41K | 0.11% | $1.28M |
Shay capital | 203.60K | 0.06% | $374.63K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Merck | 2.72M | 1.94% | 2.72M |
Vestal point capital, lp | 2.57M | 0.28% | 2.57M |
Kynam capital management, lp | 3.64M | 0.40% | 1.57M |
Blackrock | 6.91M | 0.00% | 1.21M |
Blackrock funding, inc. /de | 7.59M | 0.00% | 577.07K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 405.62K | 0.00% | -1.63M |
Baillie gifford | 48.79K | 0.00% | -1.47M |
Eversept partners, lp | 694.41K | 0.11% | -1.15M |
Bank of montreal /can/ | - | - | -814.96K |
Point72 asset management | 2.20M | 0.01% | -799.91K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Merck | 2.72M | 1.94% | 2.72M | $5.01M |
Vestal point capital, lp | 2.57M | 0.28% | 2.57M | $4.73M |
Lpl financial | 230.15K | 0.00% | 230.15K | $674.34K |
Shay capital | 203.60K | 0.06% | 203.60K | $374.63K |
Thrivent financial for lutherans | 97.10K | 0.00% | 97.10K | $178.00K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -13.00 |
Allspring global investments | -15.00 |
Us bancorp \de\ | -53.00 |
Signaturefd | -86.00 |
Rothschild investment | -200.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 121 | -9.70% | 63,450,822 | 1.49% | 77 | 1.33% | 62 | -15.07% | 35 | 9.38% |
Sep 30, 2024 | 133 | 9.02% | 62,516,015 | -1.03% | 76 | 1.26% | 73 | -7.59% | 31 | 10.71% |
Jun 30, 2024 | 122 | 3.39% | 63,167,394 | 18.26% | 77 | 1.03% | 79 | 16.18% | 28 | -12.50% |
Mar 31, 2024 | 118 | 3.51% | 53,412,278 | -3.97% | 86 | 1.05% | 68 | 11.48% | 32 | 10.34% |
Dec 31, 2023 | 114 | 3.64% | 55,621,581 | -0.54% | 91 | 1.07% | 61 | 22.00% | 29 | -12.12% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.42M | 2.93% | - |
iShares Russell 2000 ETF | 2.21M | 2.68% | -16.80K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.19M | 1.44% | - |
CREF Stock R1 | 1.03M | 1.25% | - |
Baillie Gifford Global Discovery A Acc | 904.60K | 1.10% | -13.25K |
Fidelity Small Cap Index | 839.59K | 1.02% | 6.39K |
iShares Russell 2000 Value ETF | 752.65K | 0.91% | 1.02K |
Edinburgh Worldwide Ord | 555.93K | 0.67% | -194.80K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 502.75K | 0.61% | - |
iShares Biotechnology ETF | 479.20K | 0.58% | -1.02K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 29, 2024 | Vasquez Nicki | CHIEF PORT. STRAT & ALNCE OFCR | Sell | $60.92K |
Aug 28, 2023 | Shtylla Brunilda | Chief Business Officer | Sell | $72.59K |
Aug 25, 2023 | Shtylla Brunilda | Chief Business Officer | Sell | $53.28K |
Mar 14, 2022 | NEWELL WILLIAM J | CEO | Buy | $77.51K |
Sep 28, 2021 | Vasquez Nicki | Chief Port. Strat & Alnce Ofcr | Sell | $72.72K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | 1 |
2023 Q4 | - | - |
STRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools